# Delivery and Implementation of a Randomised Crossover Trial on Thrombosis

> **NCT06937372** · NA · NOT_YET_RECRUITING · sponsor: **Queen Mary University of London** · enrollment: 21194 (estimated)

## Conditions studied

- Hip Fractures
- Venous Thromboembolism (VTE)

## Interventions

- **DRUG:** Patients in hospitals allocated to this arm will receive aspirin as their routine thromboprophylaxis after surgery.
- **DRUG:** Low molecular weight heparin (LMWH)

## Key facts

- **NCT ID:** NCT06937372
- **Lead sponsor:** Queen Mary University of London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2027-10-31
- **Final completion:** 2028-04-30
- **Target enrollment:** 21194 (ESTIMATED)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06937372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06937372, "Delivery and Implementation of a Randomised Crossover Trial on Thrombosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06937372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*